Sequenom, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 84   

Articles published

SQNM 3.50 -0.02 (-0.57%)
price chart
Why Sequenom, Inc. Stock Skyrocketed
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Illumina and Sequenom Pool Noninvasive Prenatal Testing Intellectual ...  Business Wire (press release)
Sequenom climbs after genetic analysis company ends patent dispute with ...  Fox Business
Related articles »  
Wedbush Securities Expects In-Line Results For Sequenom
In a report published Thursday, Wedbush Securities analyst Zarak Khurshid reiterated an Outperform rating and $4.50 price target on Sequenom, Inc. (NASDAQ: SQNM). In the report, Wedbush Securities noted, "SQNM appears to have roughly 30% share in ...
Analyst Rating Update on Sequenom, Inc.
Research firm Zacks has rated Sequenom Inc (NASDAQ:SQNM) and has ranked it at 3, indicating that for the short term the shares are a hold.
Sequenom, Inc. Short Interest Update  Wall Street Pulse
Why Sequenom Inc. Shares Surged
What: Shares of Sequenom (NASDAQ: SQNM ) are trading roughly 10% higher today following news that the life sciences company has gained pre-market clearance from the FDA to market its IMPACT genotyping test.
Agena Bioscience Announces FDA 510(k) Premarket Clearance of the IMPACT ...  MarketWatch
Related articles »  
Why Sequenom, Inc. Stock Scorched 23% Higher in December
What: Shares of Sequenom (NASDAQ: SQNM ) , a life sciences company focused on developing genomic and genetic analysis solutions and diagnostics, soared by 23% in December, based on data from S&P Capital IQ, after settling a long-standing legal ...
Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2014 Financial ...
SAN DIEGO, Feb. 19, 2015 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a leading molecular diagnostics company, today announced it will report financial results for the fourth quarter and full year 2014 after closing of the NASDAQ Global Market on ...
Price Target Update on Sequenom, Inc.
Sequenom, Inc. (NASDAQ:SQNM): The stock price is expected to reach $ 4.94 in the short term. The number of analysts agreeing with this consensus is 5. The higher estimate for the short term price target is at $7 while the lower estimate is at $3.
The Liquid Biopsy Will Boost Revenue For Sequenom And Illumina
The company sells equipment, reagents and service to the molecular testing space. Additionally, Illumina offers clinical genetic testing services through Verinata Health.
Company Shares of Sequenom, Inc. Drops by -3.59%
Sequenom, Inc. (NASDAQ:SQNM) has lost 3.59% during the past week and dropped 3.59% in the last 4 weeks. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 4.2%.
Sequenom, Inc. Announces Participation At The 33rd Annual J.P. Morgan ...
SAN DIEGO, Jan. 6, 2015 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a leading molecular diagnostics company, today announced the Company's participation at the 2015 J.P.
Related articles »